OpenVSafe by OpenVAERS
Search V-safe

FEX-32272-44964

2 vaccinations 2 coded responses 14 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
198 / DE
Registered
2021-10-15
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-10-01
    Dose 1 — Pfizer-BioNTech
  2. 2021-10-15
    Registered in v-safe
  3. 2021-10-15
    Dose 2 — Pfizer-BioNTech
  4. 2021-10-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-10-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains
    Adult check-in
  6. 2021-10-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-10-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  8. 2021-10-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-10-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-10-22
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-10-29
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-11-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-11-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-11-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-11-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2022-01-14
    Survey response — 3 months, dose 2
    MedDRA: Cough, Diarrhoea, Headache, Nasal congestion, Oropharyngeal pain — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Diarrhea, headache, stuffy nose, sore throat, cough
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-04-15
    Survey response — 6 months, dose 2
    MedDRA: Fatigue, Nausea, Oropharyngeal pain, Respiratory tract congestion, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Sore throat, congestion, fatigue, nausea, vomiting
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-10-01Pfizer-BioNTech No
22021-10-15Pfizer-BioNTech No

Free text

Release 10 — 3 months, dose 2

2022-01-14

Symptoms: Diarrhea, headache, stuffy nose, sore throat, cough

Release 11 — 6 months, dose 2

2022-04-15

Symptoms: Sore throat, congestion, fatigue, nausea, vomiting

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDDiarrhoea · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDNasal congestion · · ✓
SDNausea · · ✓
SDOropharyngeal pain · · ✓
SDRespiratory tract congestion · · ✓
SDVomiting · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release